Krishna Institute of Medical Sciences (KIMS) Q2 24/25 earnings summary

Executive summary

• Achieved strong growth across all key financial and operational metrics, with consolidated gross revenue of INR 782 crore in Q2 FY25, up 19.4% year-on-year and 12.9% quarter-on-quarter.

• EBITDA grew 23.8% year-on-year and 21.2% quarter-on-quarter to INR 223 crore, with margin improving to 28.5%.

• PAT reached INR 121 crore, up from INR 101 crore year-on-year and INR 95 crore quarter-on-quarter; EPS rose 16.7% year-on-year and 24.0% quarter-on-quarter.

• Expanded presence in Kerala and Andhra Pradesh through acquisitions and asset-light models, targeting underserved Tier 2 and Tier 3 cities.

• Added experienced leadership for new regional clusters to drive growth and operational excellence.

Financial highlights

• Operating revenue for Q2 FY25 was INR 7,773 million, up 19.1% year-on-year and 12.9% quarter-on-quarter.

• EBITDA margin improved to 28.7% on operating revenue.

• PAT margin stood at 15.4% for Q2 FY25.

• Average revenue per operating bed (ARPOB) grew by 22.9% year-on-year to Rs 38,263.

• IP and OP volumes increased by 9.1% and 12.2% year-on-year, respectively.

Outlook and guidance

• Targeting 3,000 beds in Kerala over 5-6 years, primarily through asset-light and O&M models.

• EBITDA margin guidance maintained at 27%-28% for the full year.

• Kerala facilities expected to achieve 25% EBITDA margin as they scale.

• Andhra Pradesh cluster margins projected to reach 27%-28% as newer hospitals mature.

• Expansion plans include new hospitals in Bangalore, Mumbai (Thane), Srikakulam, Ongole, Anantapur, and Kondapur, with significant capex and incremental bed additions expected by FY25–FY27.